Global Anti-Migraine Drugs Market – Trends and
Opportunities (2014-2019)
Scope of the Report
The report titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)”
provides a...
Executive Summary
Migraine, a condition of recurring headaches and is accompanied by symptoms like nausea,
vomiting, dizzi...
Global Anti Migraine Drugs Market
Nearly ….% people worldwide are affected by migraine, translating into a market size of ...
The US Anti-Migraine Drugs Market
The US is the largest market globally and accounted for approximately …% of total anti-m...
Table of Contents
1. Executive Summary
2. Migraine
2.1 An Overview
2.2 Different Types of Migraines
2.2.1 Migraine without...
Table of Contents
7. Upcoming Trends
7.1 Calcitonin Gene-Related Peptides (CGRP)
Antibodies
7.2 BOTOX for Migraine
7.3 Ant...
List of Charts
Figure 1: Pathways of Migraine
Table 1: Other Types of Migraines
Figure 2: Global Migraine Drugs Market Siz...
Figure 13: BOTOX Migraine Sales by Geography in US$ Million, 2012-2017
Table 9: New Products for the Treatment and Prevent...
Daedal Research
Daedal Research is a research and consulting firm specialized in providing research reports and
customized...
Upcoming SlideShare
Loading in …5
×

Global Anti Migraine Drugs Market: Trends and Opportunities (2014-19) – New Report by Daedal Research

724 views

Published on

The report titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” . For more mail me: info@daedal-research.com

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
724
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global Anti Migraine Drugs Market: Trends and Opportunities (2014-19) – New Report by Daedal Research

  1. 1. Global Anti-Migraine Drugs Market – Trends and Opportunities (2014-2019)
  2. 2. Scope of the Report The report titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value, segmentation, types of diagnosis and treatment for migraine. It also discusses key growth drivers and upcoming trends of the market. Further, key manufacturers of anti-migraine drugs like Endo International Inc, Impax Laboratories, GlaxoSmithKline and Pfizer Inc. are profiled in the report. Segments Coverage  Triptans  Ergot Alkaloids Company Coverage  Endo International Inc.  IMPAX Laboratories Inc.  GlaxoSmith Kline (GSK)  Pfizer Inc. View Report Details
  3. 3. Executive Summary Migraine, a condition of recurring headaches and is accompanied by symptoms like nausea, vomiting, dizziness and sensitivity to light and noise ranks among the World’s Top 20 disabling medical illnesses. It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other factors contributing to the growth of these drugs include awareness among the people about proper diagnosis and treatment of migraine, rise in medical expenditures and new drugs launches. Acute migraine treatment market is dominant by Triptans and most of them are available as pills. Triptans like Sumatriptan and Zolmitriptan are also available as nasal sprays whereas rizatriptan and zolmitriptan are available as tablets that dissolve in mouth. In next 5-10 years, cost of migraine drugs is anticipated to decline due to many generic entrants as most of them are losing their patents. Growing awareness of migraine in the emerging countries and fall in prices will facilitate the growth of anti-migraine drugs market. In addition, with the development of new treatment therapies like calcitonin gene-related peptides (CGRP) receptor antagonist and BOTOX the demand for anti-migraine drugs is anticipated to grow further. The US is the largest market for anti-migraine drugs and there are number of companies that manufacture these drugs. Major companies include Impax, Endo Pharmaceuticals, Pfizer, GlaxoSmith Kline, Nautilus and Allergan.
  4. 4. Global Anti Migraine Drugs Market Nearly ….% people worldwide are affected by migraine, translating into a market size of US$.... billion in 2013. Drivers contributing to the growth of migraine drugs market include awareness among the people about proper diagnosis and treatment of migraine, rise in medical expenditures and new drugs launches. Global Migraine Drugs Market Size (US$ Billion), 2009-2013 • Acute migraine treatment market is dominant by Triptans that accounted for ….% of total drugs revenue in 2013. Isometheptene are the second highest, accounting for …% of prescriptions followed by Ergots having a share of …%. Segmentation of Migraine Drugs by Types, 2013 2008 2009 2010 2011 2012 2013 Triptans Isometheptene Ergots
  5. 5. The US Anti-Migraine Drugs Market The US is the largest market globally and accounted for approximately …% of total anti-migraine drugs revenue in 2013. It is estimated that total number of acute migraine sufferers will increase from …million in 2012 to … million by 2017 and that of chronic migraine sufferers from … million in 2012 to …… million by 2017. Total Number of Migraine Sufferers in the US in Million, 2012E-2017E • Triptans account for the largest portion of overall anti-migraine drugs consumed in the US. As more triptan brands become generic in the coming years, it is expected that the demand will subsequently increase. Relpax brand manufactured by Pfizer has the highest market share. Figure 9: Market Shares of Triptan by Brands in the US, 2013 2012E 2013E 2014E 2015E 2016E 2017E Acute Migraine Sufferers Chronic Migraine Sufferers Relpax Imitrex Maxalt Zomig Frova Treximet Amerge Axert Zegenix
  6. 6. Table of Contents 1. Executive Summary 2. Migraine 2.1 An Overview 2.2 Different Types of Migraines 2.2.1 Migraine without Aura 2.2.2 Migraine with Aura 2.2.3 Other Types of Migraine 2.3 Diagnosis and Treatment 3. Anti-Migraine Drugs Market 3.1 Global Anti-Migraine Drugs Market Size (2009- 2013) 3.2 Forecast- Global Anti-Migraine Drugs Market Size (2014-2019) 3.3 Segmentation by Type of Drugs Used 3.4 Migraine Specific Drug 3.4.1 Triptan Types of Triptans Effectiveness of Triptans Triptan Costs 3.4.2 Tezampanel 3.4.3 Ergots Alkaloids 3.5 Prevalence of Migraine 4. The US Migraine Market 4.1 Migraine Sufferers 4.2 Market Size 4.3 Triptans Sales 5. Market Drivers & Challenges 5.1 Rising Healthcare Expenditures 5.2 Growth of Middle-Aged Population 5.3 Patent Expires of Migraine Drugs 6. Challenges 6.1 Strict Regulations 6.2 Expensive Drugs
  7. 7. Table of Contents 7. Upcoming Trends 7.1 Calcitonin Gene-Related Peptides (CGRP) Antibodies 7.2 BOTOX for Migraine 7.3 Anti-Migraine Headbands & Devices 7.4 New Products Development 8. Competitive Landscape 9. Company Profiles 9.1 Endo International Plc. 9.1.1 Business Description 9.1.2 Financial Overview 9.1.3 Business Strategies 9.2 IMPAX Laboratories Inc. 9.2.1 Business Description 9.2.2 Financial Overview 9.2.3 Business Strategies 9.3 GlaxoSmithKline (GSK) 9.3.1 Business Description 9.3.2 Financial Overview 9.3.3 Business Strategies 9.4 Pfizer Inc. 9.4.1 Business Description 9.4.2 Financial Overview 9.4.3 Business Strategies 10. About Us
  8. 8. List of Charts Figure 1: Pathways of Migraine Table 1: Other Types of Migraines Figure 2: Global Migraine Drugs Market Size (US$ Billion), 2009-2013 Figure 3: Forecast of Global Migraine Drugs Market (US$ Billion), 2014-2019 Figure 4: Segmentation of Migraine Drugs by Types, 2013 Table 2: Types of Triptans Currently Available Table 3: Effectiveness of Oral Triptans Table 4: Frequency of Oral Triptan Side Effects Table 5: Triptan Costs Table 6: Tezampanel Drug Market, 2013 Figure 5: Prevalence of Migraine Worldwide (2007-2013) Figure 6: Total Number of Migraine Sufferers in the US in Million, 2012E-2017E Figure 7: The US Migraine Drugs Market Size (US$ Billion), 2009 Figure 8: Share of the US in Overall Migraine Drugs Market, 2013 Figure 9: Market Shares of Triptan by Brands, 2013 Table 7: Estimated Sales of Selected Migraine Drugs in the US, 2013 Figure 10: Global Healthcare Expenditures Per Capita in US$, 2007-2013 Figure 11: World Population Ages Between 15-34 Years in Billion, 2007-2013 Table 8: Generic Availability of Select Migraine Products Figure 12: Global BOTOX Migraine Sales in US$ Million, 2012-2017
  9. 9. Figure 13: BOTOX Migraine Sales by Geography in US$ Million, 2012-2017 Table 9: New Products for the Treatment and Prevention of Migraine Figure 14: Migraine Drugs Share in Total Prescriptions, Nov 2012 vs Nov 2013 Figure 15: Migraine Drugs Share in Total Prescriptions (Excl acetaminophen products) by Players, Nov 2012 vs Nov 2013 Figure 16: Endo International Plc.- Revenue Segmentation by Business Segments, 2013 Table 10: Revenue Breakdown of Endo Pharmaceuticals Segment, 2013 Figure 17: Endo International Plc - Revenues from “Frova” (US$ Million) 2010-2013 Figure 18: Impax Laboratories – Revenue Segmentation by Business Segments, 2013 Figure 19: Revenue from Impax Division Segment, 2010-2013 (US$ Million) Figure 20: GSK Revenue Segmentation by Business Areas, 2013 Figure 21: GSK- Revenues from Imigran/Imitrex Migraine Drugs Brands (US$ Million) 2011-2013 Figure 22: GSK- Distribution of Imigran/Imitrex Migraine Drugs by Geographic Areas, 2013 Figure 23: Pfizer’s Revenue Share by Business Segments (2013) Figure 24: Pfizer – Revenues from Relpax Migraine Drug (US$ Million), 2011-2013 List of Charts
  10. 10. Daedal Research Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries. For more details please contact Mr. Rajeev Kumar: Tel: +91-120-4553017 (9.30 am - 6.30 pm) IST Mobile: +91-8743975789 (24 X7) Enquiries: info@daedal-research.com Title: Global Anti-Migraine DrugsMarket: Trends & Opportunities (2014-19) Published: June 2014 Pages: 60 Price: US$ 800 (Single-User License) : US$ 1600 (Corporate License) For placing an order of the Report, please press the following link: http://www.daedal-research.com/global-anti-migraine-drugs-market-trends-and-opportunities-2014-192

×